Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 2/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | UGT2B7 | P16662 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | HTR1A | P08908 | 3/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13801026 | 0.94 | HDAC1 (0.50) | HDAC1HDAC8MEN1KMT2ACYP2D6 | |
| SCHEMBL13801021 | 0.83 | HPGD (0.44) | KMT2ATSHRPOLBAPEX1HTT | |
| Hydrochloric Acid SCHEMBL9656190 | 0.83 | CHRNB2 (0.48) | AOC3GLAMTNR1AMTNR1BADRA2A | |
| SCHEMBL29791076 | 0.82 | PPARG (0.46) | MEN1KMT2APOLBAPEX1HTT | |
| SCHEMBL13801034 | 0.81 | HDAC1 (0.50) | HDAC1HDAC8MEN1KMT2ACYP2D6 | |
| SCHEMBL13801028 | 0.79 | TDP1 (0.36) | MEN1KMT2ACYP1A2TSHRGLA | |
| SCHEMBL13801024 | 0.76 | MTNR1A (0.39) | KMT2ATSHRMTNR1APOLBAPEX1 | |
| SCHEMBL13801022 | 0.76 | POLB (0.49) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL12383206 | 0.76 | UGT2B7 (0.47) | MEN1KMT2ACYP2D6AOC3CYP1A2 | |
| SCHEMBL235139 | 0.75 | MTNR1A (0.49) | KMT2ACYP2D6CYP1A2TSHRMTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101462957-A | Aromatic (meth)acrylate compound having an alpha-hydroxy, photosensitive polymer, resist compositions, and associated methods | CHEIL IND INC (KR) | 2009-06-24 | — | — | CN | disclosed |
| US-20090155719-A1 | Aromatic (meth)acrylate compound having an alpha-hydroxy, photosensitive polymer, resist compositions, and associated methods | CHEIL INDUSTRIES, INC. (KR) | 2009-06-18 | — | — | US | disclosed |
| US-20090155719-A1 | Aromatic (meth)acrylate compound having an alpha-hydroxy, photosensitive polymer, resist compositions, and associated methods | CHEIL INDUSTRIES, INC. (KR) | 2009-06-18 | — | — | US | disclosed |
| US-20090155719-A1 | Aromatic (meth)acrylate compound having an alpha-hydroxy, photosensitive polymer, resist compositions, and associated methods | CHEIL INDUSTRIES, INC. (KR) | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090155719-A1 | Aromatic (meth)acrylate compound having an alpha-hydroxy, photosensitive polymer, resist compositions, and associated methods | AHR, PAH, MCHR1 | HDAC1 753/4885HDAC8 1801/4885MEN1 908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.